Artificial Intelligence in Healthcare Report

This study presents an overview of the development, adoption and use of Artificial Intelligence (AI) technologies and applications in the healthcare sector across all Member States. The main aim of this study was to support the European Commission in identifying and addressing any issues that might be hindering the wider adoption of AI technologies in the healthcare sector. The study will help the Commission to take action to achieve its long-term goal on the effective implementation of AI in the healthcare sector, based around common legislation and policy framework.

According to the study, while most EU Member States have developed AI strategies that identify healthcare as a priority sector, there are no policies within those strategies targeting healthcare in particular. However, EU Member States have made progress in proposing regulatory frameworks around the management of health data, which is a foundational element for the further development of AI technologies in the healthcare sector.

In terms of adoption, while healthcare organisations in the EU are open to adopting AI applications, adoption is still currently limited to specific departments, teams and application areas. The lack of trust in AI-driven decision support is hindering the wider adoption, while issues around the integration of new technologies into current practices are also among the main challenges identified by relevant stakeholders in EU Member States.

The scientific output in the area of AI in healthcare comes mainly from the larger Member States. They are the most active countries at collaborating between themselves and with smaller Member States. Additionally, a need for further financial support has been identified to enhance the development of AI technologies, which are translated into clinical practice. It includes support for targeting the acquisition of Intellectual Property (IP) rights for the already developed technologies.

The study has highlighted 6 categories where the European Commission is suggested to focus to support the development and adoption of AI technologies in the healthcare sector across the EU. These include:

  • a policy and legal framework supporting the further development and adoption of AI aimed at the healthcare sector in particular;
  • initiatives supporting further investment in the area;
  • actions and initiatives that will enable the access, use and exchange of healthcare data with a view to using AI;
  • initiatives to upskill healthcare professionals and to educate AI developers on current clinical practices and needs;
  • actions addressing culture issues and building trust in the use of AI in the healthcare sector;
  • policies supporting the translation of research into clinical practice.

Country Factsheets

The country factsheets present an overview of the current situation in each EU Member State with regards to the development, adoption and use of Artificial Intelligence (AI) technologies and applications in the healthcare sector. The factsheets aim to support the European Commission in identifying the current state of development and adoption of AI in the healthcare sector in each Member State and identify any differences that might bring to light specific challenges and obstacles to the wider adoption across the EU.

The country factsheets are based on an analysis of the relevant legislation and policy framework around AI in each Member State. They look at the research and innovation landscape of each country in the area of AI in healthcare, the presence of cross-border collaborations in research, the start-up ecosystem in each country, and the awareness around AI technologies in the healthcare sector based on social media mentions.

While most EU Member States are taking measures towards establishing strategies around the use of AI in healthcare, most initiatives focus on the research and innovation area. There is little activity on initiatives to promote adoption by the sector itself. The start-up ecosystem varies across EU Member States and is mostly driven by private initiatives and support networks.

Finally, awareness around EU Member States on AI in healthcare as seen on social media and news sites are largely event-related, with spikes in awareness coinciding with published articles or national-level initiatives appearing in the local press.

Download: Artificial intelligence in healthcare - Final Report (3.095 KB).

Download: Artificial intelligence in healthcare - Final Country Factsheets (8.117 KB).

Download from DIGITAL HEALTH NEWS: Artificial intelligence in healthcare - Final Report (3.095 KB).

Download from DIGITAL HEALTH NEWS: Artificial intelligence in healthcare - Final Country Factsheets (8.117 KB).

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...